Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

<p>Video S2</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Alvaro Teijeira (14962650) (author)
Diğer Yazarlar: Saray Garasa (14962653) (author), Carlos Luri-Rey (14962656) (author), Carlos de Andrea (14962659) (author), Maria Gato (14962662) (author), Carmen Molina (14962665) (author), Tsuneyasu Kaisho (14962668) (author), Assunta Cirella (14962671) (author), Arantza Azpilikueta (14962674) (author), Steffanie K. Wculek (14962677) (author), Josune Egea (14962680) (author), Irene Olivera (14962683) (author), Inmaculada Rodriguez (14962686) (author), Ana Rouzaut (14962689) (author), Vladislav Verkhusha (14962692) (author), Karmele Valencia (14962695) (author), David Sancho (14962698) (author), Pedro Berraondo (14931434) (author), Ignacio Melero (14962701) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Immuno-oncology
Immunology
Dendritic cells
Immune responses to cancer
Immunotherapy
Agonist antibodies
Checkpoint blockade
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
İlk yorumlayan siz olun!
İlk önce giriş yapmalısınız

Benzer Materyaller